Patent details

EP3478664 Title: METHODS FOR THE SYNTHESIS OF DEUTERATED DEXTROMETHORPHAN

Basic Information

Publication number:
EP3478664
PCT Application Number:
US2017040623
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP177402237
PCT Publication Number:
WO2018009488
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
METHODS FOR THE SYNTHESIS OF DEUTERATED DEXTROMETHORPHAN
French Title of Invention:
PROCÉDÉS DE SYNTHÈSE DE DEXTROMÉTHORPHANE DEUTÉRÉ
German Title of Invention:
VERFAHREN ZUR SYNTHESE VON DEUTERIERTEM DEXTROMETHORPHAN
SPC Number:

Dates

Filing date:
03/07/2017
Grant date:
02/12/2020
EP Publication Date:
08/05/2019
PCT Publication Date:
11/01/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/12/2020
EP B1 Publication Date:
02/12/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
03/07/2021
Expiration date:
03/07/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
25/11/2020
 
 

Name:
Avanir Pharmaceuticals, Inc.
Address:
30 Enterprise, Suite 400, Aliso Viejo CA 92656, United States (US)

Inventor

1

Name:
LU, Zhijun
Address:
China (CN)

2

Name:
LI, Yan
Address:
China (CN)

3

Name:
MENG, Weihua
Address:
China (CN)

4

Name:
JOHNSON, Matt
Address:
United States (US)

5

Name:
ZHAO, Cunxiang
Address:
China (CN)

Priority

Priority Number:
PCT/CN2016/088414
Priority Date:
04/07/2016
Priority Country:
World Intellectual Property Office (WIPO) (WO)

Classification

IPC classification:
C07D 221/28;

Publication

European Patent Bulletin

Issue number:
202049
Publication date:
02/12/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages